Refractory adult-onset Still disease treated by tocilizumab combined with methotrexate: A STROBE-compliant article

Some patients have poor response to adult-onset Still disease (AOSD) traditional treatment, which easily recurs during the reduction of prednisone. We observed the efficacy and safety of tocilizumab combined with methotrexate (MTX) in the treatment of refractory AOSD, and to explore the possibility...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chun-yan, Guo, Shao-hua, Wang, Li-ping, Shen, Hai-li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708626/
https://www.ncbi.nlm.nih.gov/pubmed/31393368
http://dx.doi.org/10.1097/MD.0000000000016682

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708626/
https://www.ncbi.nlm.nih.gov/pubmed/31393368
http://dx.doi.org/10.1097/MD.0000000000016682

Ejemplares similares